BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 51305292 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b 5-hydroxytryptamine receptor 2A Homo sapiens 2990 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305293 CCc1cc2OCOc2cc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31N3O5/c1-2-18-13-23-24(33-17-32-23)15-21(18)29-11-9-28(10-12-29)16-20(30)7-8-27-26(31)25-14-19-5-3-4-6-22(19)34-25/h3-6,13-15,20,30H,2,7-12,16-17H2,1H3,(H,27,31) DNRUAPLXAOKCKK-UHFFFAOYSA-N 50530561 CHEMBL4465596 D(3) dopamine receptor Homo sapiens 24 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530561&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451661 440739143 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305294 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 5-hydroxytryptamine receptor 2C Homo sapiens 1260 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305295 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 5-hydroxytryptamine receptor 2A Homo sapiens 21 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305296 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 D(3) dopamine receptor Homo sapiens 46 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305297 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b 5-hydroxytryptamine receptor 2A Homo sapiens 336 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305298 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 D(3) dopamine receptor Homo sapiens 38 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305299 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530567 CHEMBL4436317::US11337971, Compound (R)-C4a D(3) dopamine receptor Homo sapiens 13 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530567 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530567&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431294 440739149 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305300 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a 5-hydroxytryptamine receptor 1A Homo sapiens 9500 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305301 CCc1cccc(N2CCN(CC(O)CCNC(=O)c3ccc4OCOc4c3)CC2)c1Cl InChI=1S/C24H30ClN3O4/c1-2-17-4-3-5-20(23(17)25)28-12-10-27(11-13-28)15-19(29)8-9-26-24(30)18-6-7-21-22(14-18)32-16-31-21/h3-7,14,19,29H,2,8-13,15-16H2,1H3,(H,26,30) CAQIBAFXOSLMJP-UHFFFAOYSA-N 50530569 CHEMBL4518618::US11337971, Compound 113b D(3) dopamine receptor Homo sapiens 3.0 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530569 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530569&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451658 440739151 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305302 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 5-hydroxytryptamine receptor 1A Homo sapiens 2800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305303 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 D(3) dopamine receptor Homo sapiens 38 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305304 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a D(3) dopamine receptor Homo sapiens >6800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305305 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b D(2) dopamine receptor Homo sapiens 10800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305306 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b D(3) dopamine receptor Homo sapiens >7500 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305307 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 5-hydroxytryptamine receptor 2C Homo sapiens 50 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305308 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 5-hydroxytryptamine receptor 1A Homo sapiens 131 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305309 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a D(2) dopamine receptor Homo sapiens 20800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305310 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a D(3) dopamine receptor Homo sapiens >5400 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305311 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a D(3) dopamine receptor Homo sapiens 510 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305312 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a 5-hydroxytryptamine receptor 1A Homo sapiens 9500 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305313 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530571 CHEMBL4527078::US11337971, Compound (S)-C4a D(3) dopamine receptor Homo sapiens 35 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530571 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530571&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431306 440739153 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305314 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a D(3) dopamine receptor Homo sapiens 0.756000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305315 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a D(3) dopamine receptor Homo sapiens 95 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305316 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a 5-hydroxytryptamine receptor 2C Homo sapiens 580 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305317 CCc1cccc(N2CCN(C[C@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530572 CHEMBL4584497::US11337971, Compound (R)-C5a D(2) dopamine receptor Homo sapiens 80 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530572 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530572&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431315 440739154 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305318 CCc1cccc(N2CCN(C[C@@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530573 CHEMBL4446609::US11337971, Compound (S)-C5a D(2) dopamine receptor Homo sapiens 891 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530573 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530573&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431288 440739155 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305319 CCc1cccc(N2CCN(C[C@@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530573 CHEMBL4446609::US11337971, Compound (S)-C5a D(3) dopamine receptor Homo sapiens 0.840000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530573 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530573&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431288 440739155 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305320 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b D(2) dopamine receptor Homo sapiens 10800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305321 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b D(3) dopamine receptor Homo sapiens >4000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305322 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b D(2) dopamine receptor Homo sapiens 328 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305323 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b D(3) dopamine receptor Homo sapiens 2.5 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305324 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b D(3) dopamine receptor Homo sapiens 450 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305325 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b 5-hydroxytryptamine receptor 1A Homo sapiens 117 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305326 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(O)CCNC(=O)c2ccc3OCOc3c2)CC1 InChI=1S/C25H32ClN3O5/c1-3-17-12-20(26)24(32-2)21(13-17)29-10-8-28(9-11-29)15-19(30)6-7-27-25(31)18-4-5-22-23(14-18)34-16-33-22/h4-5,12-14,19,30H,3,6-11,15-16H2,1-2H3,(H,27,31) IHGOJNWFGIOWTK-UHFFFAOYSA-N 50530574 CHEMBL4464971::US11337971, Compound 113a D(2) dopamine receptor Homo sapiens 364 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530574 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530574&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451691 440739156 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305327 CCc1cccc(N2CCN(CC(O)CCNC(=O)c3ccc4OCOc4c3)CC2)c1Cl InChI=1S/C24H30ClN3O4/c1-2-17-4-3-5-20(23(17)25)28-12-10-27(11-13-28)15-19(29)8-9-26-24(30)18-6-7-21-22(14-18)32-16-31-21/h3-7,14,19,29H,2,8-13,15-16H2,1H3,(H,26,30) CAQIBAFXOSLMJP-UHFFFAOYSA-N 50530569 CHEMBL4518618::US11337971, Compound 113b D(2) dopamine receptor Homo sapiens 424 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530569 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530569&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451658 440739151 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305328 CCc1cccc(N2CCN(CC(O)CCNC(=O)c3ccc4OCOc4c3)CC2)c1Cl InChI=1S/C24H30ClN3O4/c1-2-17-4-3-5-20(23(17)25)28-12-10-27(11-13-28)15-19(29)8-9-26-24(30)18-6-7-21-22(14-18)32-16-31-21/h3-7,14,19,29H,2,8-13,15-16H2,1H3,(H,26,30) CAQIBAFXOSLMJP-UHFFFAOYSA-N 50530569 CHEMBL4518618::US11337971, Compound 113b D(3) dopamine receptor Homo sapiens 3.0 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530569 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530569&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451658 440739151 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305329 CCc1cc2OCOc2cc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32N4O4/c1-2-18-14-24-25(34-17-33-24)15-23(18)30-11-9-29(10-12-30)16-20(31)7-8-27-26(32)22-13-19-5-3-4-6-21(19)28-22/h3-6,13-15,20,28,31H,2,7-12,16-17H2,1H3,(H,27,32) DGZKLXNLBCVGGK-UHFFFAOYSA-N 50530575 CHEMBL4463620 D(3) dopamine receptor Homo sapiens 4.3 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530575 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530575&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451664 440739157 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305330 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530576 CHEMBL4476394::US11337971, Compound (+-)-29 D(2) dopamine receptor Homo sapiens 13200 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530576 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530576&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431318 440739158 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305331 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530576 CHEMBL4476394::US11337971, Compound (+-)-29 D(3) dopamine receptor Homo sapiens 7.6 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530576 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530576&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431318 440739158 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305332 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 D(3) dopamine receptor Homo sapiens 7.4 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305333 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 D(3) dopamine receptor Homo sapiens >3200 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305334 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 5-hydroxytryptamine receptor 2A Homo sapiens 1933 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305335 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 D(2) dopamine receptor Homo sapiens 13500 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305336 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 D(3) dopamine receptor Homo sapiens 1020 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305337 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 5-hydroxytryptamine receptor 2A Homo sapiens 7600 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305338 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 D(2) dopamine receptor Homo sapiens 76 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305339 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 D(3) dopamine receptor Homo sapiens 0.290000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305340 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 5-hydroxytryptamine receptor 1A Homo sapiens 248 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305341 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 5-hydroxytryptamine receptor 2C Homo sapiens 50 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305342 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 D(3) dopamine receptor Homo sapiens 0.886000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305343 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 5-hydroxytryptamine receptor 2C Homo sapiens 1110 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305344 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 5-hydroxytryptamine receptor 1A Homo sapiens 2060 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305345 CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530577 CHEMBL4451683::US11337971, Compound (+-)-19 D(3) dopamine receptor Homo sapiens 0.433000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530577 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530577&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431316 440739159 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305346 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 5-hydroxytryptamine receptor 1A Homo sapiens 131 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305347 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a D(2) dopamine receptor Homo sapiens 20800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305348 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a D(3) dopamine receptor Homo sapiens 28 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305349 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a D(3) dopamine receptor Homo sapiens 510 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305350 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a 5-hydroxytryptamine receptor 2A Homo sapiens 6600 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305351 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a 5-hydroxytryptamine receptor 2C Homo sapiens >8900 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305352 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530567 CHEMBL4436317::US11337971, Compound (R)-C4a D(2) dopamine receptor Homo sapiens 21400 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530567 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530567&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431294 440739149 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305353 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530567 CHEMBL4436317::US11337971, Compound (R)-C4a D(3) dopamine receptor Homo sapiens 13 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530567 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530567&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431294 440739149 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305354 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530571 CHEMBL4527078::US11337971, Compound (S)-C4a D(2) dopamine receptor Homo sapiens 18900 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530571 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530571&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431306 440739153 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305355 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a D(2) dopamine receptor Homo sapiens 247 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305356 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a D(3) dopamine receptor Homo sapiens 95 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305357 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a 5-hydroxytryptamine receptor 1A Homo sapiens 910 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305358 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a 5-hydroxytryptamine receptor 2A Homo sapiens 620 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305359 CCc1cccc(N2CCN(C[C@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530572 CHEMBL4584497::US11337971, Compound (R)-C5a D(2) dopamine receptor Homo sapiens 80 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530572 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530572&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431315 440739154 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305360 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b D(3) dopamine receptor Homo sapiens 100 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305361 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b D(3) dopamine receptor Homo sapiens 490 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305362 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b 5-hydroxytryptamine receptor 1A Homo sapiens 2660 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305363 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b 5-hydroxytryptamine receptor 2A Homo sapiens 2990 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305364 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b D(2) dopamine receptor Homo sapiens 328 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305365 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b D(3) dopamine receptor Homo sapiens 2.5 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305366 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b 5-hydroxytryptamine receptor 2C Homo sapiens 464 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305367 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b 5-hydroxytryptamine receptor 1A Homo sapiens 351 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305368 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(O)CCNC(=O)c2ccc3OCOc3c2)CC1 InChI=1S/C25H32ClN3O5/c1-3-17-12-20(26)24(32-2)21(13-17)29-10-8-28(9-11-29)15-19(30)6-7-27-25(31)18-4-5-22-23(14-18)34-16-33-22/h4-5,12-14,19,30H,3,6-11,15-16H2,1-2H3,(H,27,31) IHGOJNWFGIOWTK-UHFFFAOYSA-N 50530574 CHEMBL4464971::US11337971, Compound 113a D(2) dopamine receptor Homo sapiens 364 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530574 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530574&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451691 440739156 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305369 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(O)CCNC(=O)c2ccc3OCOc3c2)CC1 InChI=1S/C25H32ClN3O5/c1-3-17-12-20(26)24(32-2)21(13-17)29-10-8-28(9-11-29)15-19(30)6-7-27-25(31)18-4-5-22-23(14-18)34-16-33-22/h4-5,12-14,19,30H,3,6-11,15-16H2,1-2H3,(H,27,31) IHGOJNWFGIOWTK-UHFFFAOYSA-N 50530574 CHEMBL4464971::US11337971, Compound 113a D(3) dopamine receptor Homo sapiens 25 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530574 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530574&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451691 440739156 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305370 CCc1cccc(N2CCN(CC(O)CCNC(=O)c3ccc4OCOc4c3)CC2)c1Cl InChI=1S/C24H30ClN3O4/c1-2-17-4-3-5-20(23(17)25)28-12-10-27(11-13-28)15-19(29)8-9-26-24(30)18-6-7-21-22(14-18)32-16-31-21/h3-7,14,19,29H,2,8-13,15-16H2,1H3,(H,26,30) CAQIBAFXOSLMJP-UHFFFAOYSA-N 50530569 CHEMBL4518618::US11337971, Compound 113b D(2) dopamine receptor Homo sapiens 424 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530569 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530569&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451658 440739151 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305371 CCc1cc2OCOc2cc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31N3O5/c1-2-18-13-23-24(33-17-32-23)15-21(18)29-11-9-28(10-12-29)16-20(30)7-8-27-26(31)25-14-19-5-3-4-6-22(19)34-25/h3-6,13-15,20,30H,2,7-12,16-17H2,1H3,(H,27,31) DNRUAPLXAOKCKK-UHFFFAOYSA-N 50530561 CHEMBL4465596 D(2) dopamine receptor Homo sapiens 1440 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530561&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451661 440739143 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305372 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530576 CHEMBL4476394::US11337971, Compound (+-)-29 D(2) dopamine receptor Homo sapiens 13200 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530576 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530576&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431318 440739158 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305373 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 D(2) dopamine receptor Homo sapiens 10800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305374 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 D(3) dopamine receptor Homo sapiens >3200 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305375 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 D(3) dopamine receptor Homo sapiens 350 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305376 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 5-hydroxytryptamine receptor 2A Homo sapiens 1933 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305377 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 D(2) dopamine receptor Homo sapiens 13500 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305378 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 D(3) dopamine receptor Homo sapiens >6800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305379 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 5-hydroxytryptamine receptor 2A Homo sapiens 7600 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305380 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 5-hydroxytryptamine receptor 2C Homo sapiens 5670 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305381 CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530577 CHEMBL4451683::US11337971, Compound (+-)-19 D(2) dopamine receptor Homo sapiens 132 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530577 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530577&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431316 440739159 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305382 CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530577 CHEMBL4451683::US11337971, Compound (+-)-19 D(3) dopamine receptor Homo sapiens 0.433000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530577 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530577&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431316 440739159 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305383 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 D(2) dopamine receptor Homo sapiens 76 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305384 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 D(3) dopamine receptor Homo sapiens 0.290000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305385 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 D(3) dopamine receptor Homo sapiens >2200 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305386 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 D(3) dopamine receptor Homo sapiens 19 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305387 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 5-hydroxytryptamine receptor 1A Homo sapiens 248 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305388 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 D(3) dopamine receptor Homo sapiens 46 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305389 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 D(3) dopamine receptor Homo sapiens 660 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305390 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 5-hydroxytryptamine receptor 1A Homo sapiens 2060 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305391 CCc1cc2OCOc2cc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31N3O5/c1-2-18-13-23-24(33-17-32-23)15-21(18)29-11-9-28(10-12-29)16-20(30)7-8-27-26(31)25-14-19-5-3-4-6-22(19)34-25/h3-6,13-15,20,30H,2,7-12,16-17H2,1H3,(H,27,31) DNRUAPLXAOKCKK-UHFFFAOYSA-N 50530561 CHEMBL4465596 D(2) dopamine receptor Homo sapiens 1440 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530561&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451661 440739143 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305392 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 D(2) dopamine receptor Homo sapiens 10800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305393 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 5-hydroxytryptamine receptor 1A Homo sapiens 2800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305394 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 D(3) dopamine receptor Homo sapiens >6800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305395 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 5-hydroxytryptamine receptor 2C Homo sapiens 5670 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305396 CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530577 CHEMBL4451683::US11337971, Compound (+-)-19 D(2) dopamine receptor Homo sapiens 132 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530577 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530577&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431316 440739159 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305397 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 D(3) dopamine receptor Homo sapiens 19 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305398 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 5-hydroxytryptamine receptor 1A Homo sapiens 1050 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305399 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 D(2) dopamine receptor Homo sapiens 219 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305400 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 5-hydroxytryptamine receptor 2A Homo sapiens 940 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305401 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530567 CHEMBL4436317::US11337971, Compound (R)-C4a D(2) dopamine receptor Homo sapiens 21400 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530567 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530567&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431294 440739149 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305402 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a D(2) dopamine receptor Homo sapiens 247 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305403 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a 5-hydroxytryptamine receptor 2A Homo sapiens 620 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305404 CCc1cccc(N2CCN(C[C@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530572 CHEMBL4584497::US11337971, Compound (R)-C5a D(3) dopamine receptor Homo sapiens 0.373000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530572 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530572&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431315 440739154 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305405 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b D(3) dopamine receptor Homo sapiens 100 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305406 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b 5-hydroxytryptamine receptor 2C Homo sapiens 1780 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305407 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b D(3) dopamine receptor Homo sapiens >7500 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305408 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b 5-hydroxytryptamine receptor 2C Homo sapiens 464 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305409 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(O)CCNC(=O)c2ccc3OCOc3c2)CC1 InChI=1S/C25H32ClN3O5/c1-3-17-12-20(26)24(32-2)21(13-17)29-10-8-28(9-11-29)15-19(30)6-7-27-25(31)18-4-5-22-23(14-18)34-16-33-22/h4-5,12-14,19,30H,3,6-11,15-16H2,1-2H3,(H,27,31) IHGOJNWFGIOWTK-UHFFFAOYSA-N 50530574 CHEMBL4464971::US11337971, Compound 113a D(3) dopamine receptor Homo sapiens 25 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530574 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530574&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451691 440739156 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305410 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b D(3) dopamine receptor Homo sapiens 450 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305411 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 5-hydroxytryptamine receptor 1A Homo sapiens 1050 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305412 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 D(3) dopamine receptor Homo sapiens 660 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305413 CCc1cccc(N2CCN(C[C@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530572 CHEMBL4584497::US11337971, Compound (R)-C5a D(3) dopamine receptor Homo sapiens 0.373000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530572 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530572&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431315 440739154 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305414 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a D(3) dopamine receptor Homo sapiens 0.756000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305415 CCc1cccc(N2CCN(C[C@@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530573 CHEMBL4446609::US11337971, Compound (S)-C5a D(2) dopamine receptor Homo sapiens 891 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530573 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530573&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431288 440739155 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305416 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b D(3) dopamine receptor Homo sapiens >4000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305417 CCc1cc2OCOc2cc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31N3O5/c1-2-18-13-23-24(33-17-32-23)15-21(18)29-11-9-28(10-12-29)16-20(30)7-8-27-26(31)25-14-19-5-3-4-6-22(19)34-25/h3-6,13-15,20,30H,2,7-12,16-17H2,1H3,(H,27,31) DNRUAPLXAOKCKK-UHFFFAOYSA-N 50530561 CHEMBL4465596 D(3) dopamine receptor Homo sapiens 24 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530561&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451661 440739143 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305418 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 D(3) dopamine receptor Homo sapiens 7.4 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305419 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 5-hydroxytryptamine receptor 1A Homo sapiens 4980 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305420 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 D(2) dopamine receptor Homo sapiens 219 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305421 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 5-hydroxytryptamine receptor 2A Homo sapiens 940 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305422 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a D(3) dopamine receptor Homo sapiens 28 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305423 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a 5-hydroxytryptamine receptor 2C Homo sapiens >8900 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305424 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530571 CHEMBL4527078::US11337971, Compound (S)-C4a D(2) dopamine receptor Homo sapiens 18900 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530571 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530571&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431306 440739153 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305425 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a D(3) dopamine receptor Homo sapiens >6800 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305426 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b 5-hydroxytryptamine receptor 1A Homo sapiens 2660 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305427 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 D(3) dopamine receptor Homo sapiens 350 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305428 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 5-hydroxytryptamine receptor 1A Homo sapiens 4980 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305429 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 D(3) dopamine receptor Homo sapiens >2200 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305430 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a D(3) dopamine receptor Homo sapiens >5400 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305431 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530571 CHEMBL4527078::US11337971, Compound (S)-C4a D(3) dopamine receptor Homo sapiens 35 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530571 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530571&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431306 440739153 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305432 CCc1cc2OCOc2cc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32N4O4/c1-2-18-14-24-25(34-17-33-24)15-23(18)30-11-9-29(10-12-30)16-20(31)7-8-27-26(32)22-13-19-5-3-4-6-21(19)28-22/h3-6,13-15,20,28,31H,2,7-12,16-17H2,1H3,(H,27,32) DGZKLXNLBCVGGK-UHFFFAOYSA-N 50530575 CHEMBL4463620 D(3) dopamine receptor Homo sapiens 4.3 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530575 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530575&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451664 440739157 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305433 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32ClFN4O2/c1-3-18-14-21(27)25(34-2)24(15-18)32-12-10-31(11-13-32)17-20(28)8-9-29-26(33)23-16-19-6-4-5-7-22(19)30-23/h4-7,14-16,20,30H,3,8-13,17H2,1-2H3,(H,29,33) CSFWIRRKNFTOOA-UHFFFAOYSA-N 50530568 CHEMBL4534566::US11337971, Compound C4a 5-hydroxytryptamine receptor 2A Homo sapiens 6600 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530568&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431295 440739150 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305434 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a 5-hydroxytryptamine receptor 1A Homo sapiens 910 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305435 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b D(3) dopamine receptor Homo sapiens 490 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305436 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b 5-hydroxytryptamine receptor 1A Homo sapiens 351 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305437 CCc1cc2OCOc2cc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32N4O4/c1-2-18-14-24-25(34-17-33-24)15-23(18)30-11-9-29(10-12-30)16-20(31)7-8-27-26(32)22-13-19-5-3-4-6-21(19)28-22/h3-6,13-15,20,28,31H,2,7-12,16-17H2,1H3,(H,27,32) DGZKLXNLBCVGGK-UHFFFAOYSA-N 50530575 CHEMBL4463620 D(2) dopamine receptor Homo sapiens 537 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530575 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530575&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451664 440739157 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305438 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530570 CHEMBL4515234::US11337971, Compound C5a 5-hydroxytryptamine receptor 2C Homo sapiens 580 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530570&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431289 440739152 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305439 CCc1cccc(N2CCN(C[C@@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H30ClFN4O/c1-2-18-7-5-9-23(24(18)26)31-14-12-30(13-15-31)17-20(27)10-11-28-25(32)22-16-19-6-3-4-8-21(19)29-22/h3-9,16,20,29H,2,10-15,17H2,1H3,(H,28,32) OTSVAHKQZLNXPN-UHFFFAOYSA-N 50530573 CHEMBL4446609::US11337971, Compound (S)-C5a D(3) dopamine receptor Homo sapiens 0.840000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530573 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530573&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431288 440739155 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305440 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C26H31ClFN3O3/c1-3-18-14-21(27)25(33-2)22(15-18)31-12-10-30(11-13-31)17-20(28)8-9-29-26(32)24-16-19-6-4-5-7-23(19)34-24/h4-7,14-16,20H,3,8-13,17H2,1-2H3,(H,29,32) PYUXUZVGGSSQTN-UHFFFAOYSA-N 50530560 CHEMBL4546210::US11337971, Compound C4b 5-hydroxytryptamine receptor 2C Homo sapiens 1780 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530560&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431291 440739142 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305441 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b 5-hydroxytryptamine receptor 1A Homo sapiens 117 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51305442 CCc1cc2OCOc2cc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H32N4O4/c1-2-18-14-24-25(34-17-33-24)15-23(18)30-11-9-29(10-12-30)16-20(31)7-8-27-26(32)22-13-19-5-3-4-6-21(19)28-22/h3-6,13-15,20,28,31H,2,7-12,16-17H2,1H3,(H,27,32) DGZKLXNLBCVGGK-UHFFFAOYSA-N 50530575 CHEMBL4463620 D(2) dopamine receptor Homo sapiens 537 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530575 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530575&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146451664 440739157 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51305443 CCc1cc(Cl)c(OC)c(c1)N1CCN(CC(O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530576 CHEMBL4476394::US11337971, Compound (+-)-29 D(3) dopamine receptor Homo sapiens 7.6 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530576 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530576&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431318 440739158 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305444 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530566 CHEMBL4570554::US11337971, Compound (S)-29 D(3) dopamine receptor Homo sapiens 1020 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530566&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431328 440739148 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305445 CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530563 CHEMBL4519938::US11337971, Compound (R)-19 5-hydroxytryptamine receptor 2A Homo sapiens 21 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530563&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431314 440739145 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305446 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 D(3) dopamine receptor Homo sapiens 0.886000 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51305447 CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl |r| InChI=1S/C25H31ClN4O2/c1-2-18-7-5-9-23(24(18)26)30-14-12-29(13-15-30)17-20(31)10-11-27-25(32)22-16-19-6-3-4-8-21(19)28-22/h3-9,16,20,28,31H,2,10-15,17H2,1H3,(H,27,32) OIRZLTZLOKARTG-UHFFFAOYSA-N 50530564 CHEMBL4483569::US11337971, Compound (S)-19 5-hydroxytryptamine receptor 2C Homo sapiens 1110 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530564&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431319 440739146 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51305448 CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C25H29ClFN3O2/c1-2-18-7-5-8-21(24(18)26)30-14-12-29(13-15-30)17-20(27)10-11-28-25(31)23-16-19-6-3-4-9-22(19)32-23/h3-9,16,20H,2,10-15,17H2,1H3,(H,28,31) RPKWQRUGASWUBS-UHFFFAOYSA-N 50530565 CHEMBL4553059::US11337971, Compound C5b 5-hydroxytryptamine receptor 2A Homo sapiens 336 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530565&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 130431296 440739147 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51305449 CCc1cc(Cl)c(OC)c(c1)N1CCN(C[C@H](O)CCNC(=O)c2cc3ccccc3[nH]2)CC1 |r| InChI=1S/C26H33ClN4O3/c1-3-18-14-21(27)25(34-2)24(15-18)31-12-10-30(11-13-31)17-20(32)8-9-28-26(33)23-16-19-6-4-5-7-22(19)29-23/h4-7,14-16,20,29,32H,3,8-13,17H2,1-2H3,(H,28,33) NRSBRNRWCATXOT-UHFFFAOYSA-N 50530562 CHEMBL4555827::US11337971, Compound (R)-29 5-hydroxytryptamine receptor 2C Homo sapiens 1260 ChEMBL 10.1021/acs.jmedchem.9b00607 10.7270/Q2TF01S8 31526003 Shaik, AB; Kumar, V; Bonifazi, A; Guerrero, AM; Cemaj, SL; Gadiano, A; Lam, J; Xi, ZX; Rais, R; Slusher, BS; Newman, AH 10/24/2019 2/26/2021 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50530562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50530562&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 130431329 440739144 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28